Clinical performance and utility of a NNMT-based urine test for bladder cancer

No abstract is available for this paper.

• Publication year

  2018

• Venue

  International Journal of Biological Markers

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.5301/ijbm.5000311PMID 29148015
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of nicotinamide N-methyltransferase in non-small cell lung cancer: in vitro effect of shRNA-mediated gene silencing on tumourigenicity

  2015cited by this paper
• Molecular Markers for Bladder Cancer Screening, Early Diagnosis, and Surveillance: The WHO/ICUD Consensus

  2014cited by this paper
• Down-Regulation of Nicotinamide N-methyltransferase Induces Apoptosis in Human Breast Cancer Cells via the Mitochondria-Mediated Pathway

  2014cited by this paper
• Aurora A Kinase as a diagnostic urinary marker for urothelial bladder cancer

  2014cited by this paper
• MULTIPLEX URINARY TESTS FOR BLADDER CANCER DIAGNOSIS.

  2013cited by this paper
• Nicotinamide N-methyltransferase in Non-small Cell Lung Cancer: Promising Results for Targeted Anti-cancer Therapy

  2013cited by this paper
• Upregulation of Tissue and Urinary Nicotinamide N-Methyltransferase in Bladder Cancer: Potential for the Development of a Urine-Based Diagnostic Test

  2013cited by this paper
• RNA-Mediated Gene Silencing of Nicotinamide N-Methyltransferase Is Associated with Decreased Tumorigenicity in Human Oral Carcinoma Cells

  2013cited by this paper
• Recent advances in the diagnosis and treatment of bladder cancer

  2013cited by this paper
• Expression of Engrailed-2 (EN2) protein in bladder cancer and its potential utility as a urinary diagnostic biomarker.

  2013cited by this paper
• Neuroprotective Effects of Nicotinamide N‐Methyltransferase and its Metabolite 1‐Methylnicotinamide

  2013cited by this paper
• Analysis of tissue and salivary nicotinamide N-methyltransferase in oral squamous cell carcinoma: basis for the development of a noninvasive diagnostic test for early-stage disease

  2012cited by this paper
• Evidence of abnormal tyrosine phosphorylated proteins in the urine of patients with bladder cancer: the road toward a new diagnostic tool?

  2011cited by this paper
• Nicotinamide blocks proliferation and induces apoptosis of chronic lymphocytic leukemia cells through activation of the p53/miR-34a/SIRT1 tumor suppressor network.

  2011cited by this paper
• Cancer stem cell overexpression of nicotinamide N-methyltransferase enhances cellular radiation resistance.

  2011cited by this paper
• A Four-Gene Signature Predicts Disease Progression in Muscle Invasive Bladder Cancer

  2011cited by this paper
• Nicotinamide N-methyltransferase induces cellular invasion through activating matrix metalloproteinase-2 expression in clear cell renal cell carcinoma cells.

  2011cited by this paper
• Inhibiting Proliferation in KB Cancer Cells by RNA Interference-Mediated Knockdown of Nicotinamide N-Methyltransferase Expression

  2011cited by this paper
• The expression of nicotinamide N-methyltransferase increases ATP synthesis and protects SH-SY5Y neuroblastoma cells against the toxicity of Complex I inhibitors.

  2011cited by this paper
• Structural basis of substrate recognition in human nicotinamide N-methyltransferase.

  2011cited by this paper
• Nicotinamide N-methyltransferase (NNMT) and 1-methylnicotinamide (MNA) in experimental hepatitis induced by concanavalin A in the mouse

  2010cited by this paper
• Nicotinamide N-Methyltransferase upregulation correlates with tumour differentiation in oral squamous cell carcinoma.

  2010cited by this paper
• Clinical experience with survivin as a biomarker for urothelial bladder cancer

  2010cited by this paper
• Expression and functional significance of nicotinamide N-methyl transferase in skeletal muscles of patients with chronic obstructive pulmonary disease.

  2010cited by this paper
• Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

  2010cited by this paper
• Strategies for molecular expression profiling in bladder cancer

  2009cited by this paper
• Activation of nicotinamide N-methyltrasferase and increased formation of 1-methylnicotinamide (MNA) in atherosclerosis

  2009cited by this paper
• Application of new technology in bladder cancer diagnosis and treatment

  2009cited by this paper
• Overlapping gene expression profiles of cell migration and tumor invasion in human bladder cancer identify metallothionein 1E and nicotinamide N-methyltransferase as novel regulators of cell migration

  2008cited by this paper
• 1-Methylnicotinamide (MNA) prevents endothelial dysfunction in hypertriglyceridemic and diabetic rats.

  2008cited by this paper
• Therapeutic Potential of 1-Methylnicotinamide against Acute Gastric Lesions Induced by Stress: Role of Endogenous Prostacyclin and Sensory Nerves

  2008cited by this paper
• Profiling of mRNA Expression in Quadriceps of Patients with COPD and Muscle Wasting

  2008cited by this paper
• 1‐Methylnicotinamide (MNA), a primary metabolite of nicotinamide, exerts anti‐thrombotic activity mediated by a cyclooxygenase‐2/prostacyclin pathway

  2007cited by this paper
• Nicotinamide N-Methyltransferase Upregulation Inversely Correlates with Lymph Node Metastasis in Oral Squamous Cell Carcinoma

  2007cited by this paper
• Overexpression of nicotinamide N-methyltransferase in gastric cancer tissues and its potential post-translational modification

  2006cited by this paper
• Differentiating pancreatic lesions by microarray and QPCR analysis of pancreatic juice RNAs

  2006cited by this paper
• Identification of nicotinamide N-methyltransferase as a novel tumor marker for renal clear cell carcinoma.

  2006cited by this paper
• Are poly(ADP-ribosyl)ation by PARP-1 and deacetylation by Sir2 linked?

  2003cited by this paper
• Enhanced expression of nicotinamide N-methyltransferase in human papillary thyroid carcinoma cells.

  2003cited by this paper
• Expression of Nicotinamide N‐Methyltransferase (E.C. 2.1.1.1) in the Parkinsonian Brain

  2002cited by this paper
• Differential gene expression profiling in human brain tumors.

  2001cited by this paper
• Human liver nicotinamide N-methyltransferase. cDNA cloning, expression, and biochemical characterization.

  1994cited by this paper

• Role of NNMT and NM23A for diagnosis of RCC: Renal Cell Carcinoma

  2025cites this paper
• New Perspectives on the Role of Liquid Biopsy in Bladder Cancer: Applicability to Precision Medicine

  2024cites this paper
• Exploring NNMT: from metabolic pathways to therapeutic targets

  2024cites this paper
• Identification of 1-Methylnicotinamide as a specific biomarker for the progression of cirrhosis to hepatocellular carcinoma

  2024cites this paper
• Nicotinamide N-Methyltransferase (NNMT) is Involved in Gastric Adenocarcinoma Immune Infiltration by Driving Amino Acid Metabolism

  2024cites this paper
• Proteomics Profiling of Bladder Cancer Tissues from Early to Advanced Stages Reveals NNMT and GALK1 as Biomarkers for Early Detection and Prognosis of BCa

  2023cites this paper
• Nicotinamide N-Methyl Transferase as a Predictive Marker of Tubular Fibrosis in CKD

  2023cites this paper
• Claudin-4: A New Molecular Target for Epithelial Cancer Therapy

  2023cites this paper
• Nicotinamide N-Methyltransferase: A Promising Biomarker and Target for Human Cancer Therapy

  2022cites this paper
• Biomarkers of Bladder Cancer: Cell-Free DNA, Epigenetic Modifications and Non-Coding RNAs

  2022cites this paper
• Pathology of Urologic Cancers

  2022cites this paper
• Tumor stromal nicotinamide N-methyltransferase overexpression as a prognostic biomarker for poor clinical outcome in early-stage colorectal cancer

  2022cites this paper
• Hypomethylation of CLDN4 Gene Promoter Is Associated with Malignant Phenotype in Urinary Bladder Cancer

  2022cites this paper
• Nicotinamide N-methyltransferase in endothelium protects against oxidant stress-induced endothelial injury.

  2021cites this paper
• Research Progress of Urine Biomarkers in the Diagnosis, Treatment, and Prognosis of Bladder Cancer.

  2021cites this paper
• Nicotinamide N‐methyltransferase gene silencing enhances chemosensitivity of melanoma cell lines

  2021cites this paper
• Tumoral markers in bladder cancer (Review).

  2021cites this paper
• The Utility of Nicotinamide N-Methyltransferase as a Potential Biomarker to Predict the Oncological Outcomes for Urological Cancers: An Update

  2021cites this paper
• Beyond Nicotinamide Metabolism: Potential Role of Nicotinamide N-Methyltransferase as a Biomarker in Skin Cancers

  2021cites this paper
• Proteomic profiling of bladder cancer for precision medicine in the clinical setting: A review for the busy urologist

  2020cites this paper
• Scale-Up Evaluation of a Composite Tumor Marker Assay for the Early Detection of Renal Cell Carcinoma

  2020cites this paper
• Cancer stem cell enrichment is associated with enhancement of nicotinamide N‐methyltransferase expression

  2020cites this paper
• Differential expression of nicotinamide N‐methyltransferase in primary and recurrent ameloblastomas and odontogenic keratocysts

  2020cites this paper
• High stromal nicotinamide N‐methyltransferase (NNMT) indicates poor prognosis in colorectal cancer

  2020cites this paper
• Elevated N‐methyltransferase expression induced by hepatic stellate cells contributes to the metastasis of hepatocellular carcinoma via regulation of the CD44v3 isoform

  2019cites this paper
• Bioinformatic identification of differentially expressed genes associated with prognosis of locally advanced lymph node-positive prostate cancer

  2019cites this paper
• Current and emerging bladder cancer biomarkers with an emphasis on urine biomarkers

  2019cites this paper
• Nicotinamide N-Methyltransferase and Its Precursor Substrate Methionine Directly and Indirectly Control Malignant Metabolism During Progression of Renal Cell Carcinoma

  2019cites this paper
• Nicotinamide N‐methyltransferase in nonmelanoma skin cancers

  2019cites this paper
• Urinary Markers in Bladder Cancer: An Update

  2018cites this paper
• Biomarkers for Bladder Cancer: Present Challenges and Recent Developments

  2018cites this paper
• Nicotinamide N-methyltransferase as a potential marker for cancer.

  2018cites this paper